Astra-Sanofi's RSV therapy 'highly effective' against infant hospitalizations, CDC study shows-June 2024-www.financetom.com

Astra-Sanofi's RSV therapy 'highly effective' against infant hospitalizations, CDC study shows

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Astra-Sanofi's RSV therapy 'highly effective' against infant hospitalizations, CDC study shows

Mar 7, 2024 11:17 AM

March 7 (Reuters) - AstraZeneca ( AZN ) and Sanofi's

antibody therapy was 90% effective in protecting

infants from hospitalizations associated with respiratory

syncytial virus (RSV), a study by the U.S. Centers of Disease

Control and Prevention showed on Thursday.

Previous page： BRIEF-Novelis Inc Says Plans To Withdraw IPO- SEC Filing Next page： Pfizer CEO plans to meet activist investor Starboard Value, FT reports

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BRIEF-Novelis Inc Says Plans To Withdraw IPO- SEC Filing

Oct 10, 2024

Oct 8 (Reuters) - Novelis Inc: * NOVELIS INC - PLANS TO WITHDRAW IPO- SEC FILING Source text for Eikon: Further company coverage: ...

Pfizer CEO plans to meet activist investor Starboard Value, FT reports

Oct 10, 2024

(Reuters) - Pfizer ( PFE ) CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing people familiar with the matter. Bourla and at least one other director will hold talks with Starboard next week, the report said. Pfizer ( PFE ) declined to comment, while Starboard Value did not immediately respond to...

BRIEF-Inovalis Real Estate Investment Trust Provides Update On Sale Of Sabliere Property

Oct 10, 2024

Inovalis Real Estate Investment Trust: * INOVALIS REAL ESTATE INVESTMENT TRUST PROVIDES UPDATE ON SALE OF SABLIERE PROPERTY * INOVALIS REAL ESTATE INVESTMENT TRUST - TERMINATES LETTER OF INTENT TO SELL SABLIERE PROPERTY * INOVALIS REAL ESTATE INVESTMENT TRUST: WILL CONTINUE TO EVALUATE OPPORTUNITIES FOR SALE OF SABLIERE PROPERTY Source text for Eikon: Further company coverage: ...

Build-a-bear Workshop Insider Sold Shares Worth $1,700,484, According to a Recent SEC Filing

Oct 10, 2024

05:08 PM EDT, 10/08/2024 (MT Newswires) -- Sharon Price John, Director, President and CEO, on October 08, 2024, sold 48,325 shares in Build-a-bear Workshop (BBW) for $1,700,484. Following the Form 4 filing with the SEC, John has control over a total of 416,679 shares of the company, with 416,679 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1113809/000106299324017485/xslF345X05/form4.xml ...